Basit öğe kaydını göster

dc.contributor.authorCag, Murat
dc.contributor.authorErgoren, Mahmut C.
dc.contributor.authorGul, Şeref
dc.contributor.authorYuksel, Zafer
dc.contributor.authorOzdemir, Yesim
dc.date.accessioned2023-02-21T10:21:38Z
dc.date.available2023-02-21T10:21:38Z
dc.date.issued2022
dc.identifier.citationOzdemir Y., Cag M., Gul Ş., Yuksel Z., Ergoren M. C., "In Silico Analysis of a De Novo OTC Variant as a Cause of Ornithine Transcarbamylase Deficiency", APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, cilt.30, sa.2, ss.153-156, 2022
dc.identifier.issn1541-2016
dc.identifier.otherav_4269d173-e769-4033-9cb1-b1c58a3cd563
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/188334
dc.identifier.urihttps://doi.org/10.1097/pai.0000000000000979
dc.description.abstractOrnithine transcarbamylase deficiency (OTCD) is the most common X-linked hereditary disorder of urea cycle disorders that is caused by neonatal hyperammonemia. OTC gene sequence variations are common causes of OTCD. The current study presents a 28-month-old baby girl proband with phenotypical characteristics of OTCD such as irritability, somnolence, intermittent vomiting, and high levels of serum ammonium. Whole-exome sequencing revealed a de novo c.275G > A p. (Arg92Gln) variant within the OTC gene. In silico analysis revealed a possible differential affinity between wild-type and mutant OTCase, while Arg92Gln decreases the binding ability of OTCase to the substrate, which can disrupt the urea cycle and explains the molecular pathogenicity of clinical hyper-ammonemia. In light of the fact that the genotype and phenotype correlation of OTCD is still uncertain, the present in silico analysis outcome can enhance our knowledge on this complicated, rare, and severe genetic disorder.
dc.language.isoeng
dc.subjectCerrahi Tıp Bilimleri
dc.subjectPatoloji
dc.subjectYaşam Bilimleri
dc.subjectSağlık Bilimleri
dc.subjectTemel Tıp Bilimleri
dc.subjectAnatomi
dc.subjectBiyokimya
dc.subjectTemel Bilimler
dc.subjectTıbbi Laboratuvar Teknolojisi
dc.subjectPatoloji ve Adli Tıp
dc.subjectHistoloji
dc.subjectBiyokimya (tıbbi)
dc.subjectPATOLOJİ
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectTIBBİ LABORATUVAR TEKNOLOJİSİ
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectBiyoloji ve Biyokimya
dc.subjectANATOMİ VE MORFOLOJİ
dc.titleIn Silico Analysis of a De Novo OTC Variant as a Cause of Ornithine Transcarbamylase Deficiency
dc.typeMakale
dc.relation.journalAPPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
dc.contributor.departmentÜsküdar Üniversitesi , ,
dc.identifier.volume30
dc.identifier.issue2
dc.identifier.startpage153
dc.identifier.endpage156
dc.contributor.firstauthorID4227588


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster